Emkay's research report on DCM Shriram
Consolidated revenues at Rs 12bn was down 18%yoy, marginally lower than our estimates due to lower than estimated revenues from seed and sugar business
Consolidated EBITDA at Rs 383mn was down 61%yoy and lower than our estimates due to write off in the international seed business and higher than expected inventory valuation loss for the sugar business. EBITDA margins thus contracted by ~360bps and stood at 3.2%
Given the sharp fall in caustic soda & PVC prices, lower average sugar realizations and losses in the international seed business, we have revised our FY15E/16E lower by 14%/18% respectively. We have rolled forward our SoTP based valuation to FY16E while reducing our target price to Rs 229; maintain Accumulate", says Emkay Global Financial Services research report.
For all recommendations, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
Read More
